Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rocket Pharmaceuticals (RCKT) Treasury Shares: 2016-2025

Historic Treasury Shares for Rocket Pharmaceuticals (RCKT) over the last 1 years, with Jun 2023 value amounting to $47,000.

  • Rocket Pharmaceuticals' Treasury Shares was N/A to $47,000 in Q2 2023 from the same period last year, while for Jun 2023 it was $47,000, marking a year-over-year change of. This contributed to the annual value of $47,000 for FY2022, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Rocket Pharmaceuticals' Treasury Shares is $5.5 million, which was up 25.47% from $4.4 million recorded in Q2 2025.
  • In the past 5 years, Rocket Pharmaceuticals' Treasury Shares ranged from a high of $5.7 million in Q4 2023 and a low of $2,571 during Q1 2023.
  • Over the past 3 years, Rocket Pharmaceuticals' median Treasury Shares value was $2.9 million (recorded in 2024), while the average stood at $3.0 million.
  • Data for Rocket Pharmaceuticals' Treasury Shares shows a maximum YoY slumped of 92.07% (in 2019) over the last 5 years.
  • Quarterly analysis of 4 years shows Rocket Pharmaceuticals' Treasury Shares stood at $53,000 in 2019, then tumbled by 77.91% to $76,000 in 2020, then reached $47,000 in 2022, then reached $47,000 in 2023.
  • Its last three reported values are $47,000 in Q2 2023, $47,000 for Q1 2023, and $47,000 during Q4 2022.